Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conferenceseries Ltd: World’s leading Event Organizer

Conference Series Conferences gaining more Readers and Visitors

Conference Series Web Metrics at a Glance

  • 3000+ Global Events
  • 25 Million+ Visitors
  • 25000+ unique visitors per conference
  • 70000+ page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Global Pharmacovigilance 2018

About Conference

With the grand success of Pharmacovigilance Series of Conferences in UK, USA in consecutive years over the last several years which met with great achievement in Business Conferencing. It’s glad to announce 12th Global Pharmacovigilance & Drug Safety Summit during July 09-10, 2018 Sydney, Australia with the theme “Comprehend Multiple Facets of Pharmacovigilance, Drug Safety and Clinical Trials”. This is a 2 day Mega Event offering Exhibition, at venue to showcase the new and emerging technologies with Keynote presentation, OralYRF (Student Presentation), postere-poster Presentations. 

Track 1: Drug Safety

Concept of drug safety is also known as Medication Safety in the field of health. It is associated with adverse effects of Pharmaceutical products involving many other scientific aspects, such as the side effects of drugs, the quality of medications, medication error in usage of drugs, lack of efficacy of drugs, and counterfeit drugs. Patient Safety, Drug Interaction (drug–drug and food–drug interaction) Drug Pharmacokinetic, and Adverse Drug Reaction are several terms involved with Drug Safety. Companies have to conduct a complete drug safety and pharmacovigilance audit to gauge their compliance with international standards of laws, regulations, and guidance.

In this track we will be focusing on Drug Safety Updates, Drug Safety Solutions, Training, Surveillance, Services & Software, Reporting & Monitoring.

Related Societies and Associations:

International Society for PharmacoepidemiologyCenter for Drug Safety and Effectiveness,  , International Pharmaceutical FederationInternational Society of Pharmacovigilance , Society for Clinical TrialsAssociation of Clinical ResearchThe Society of Clinical Research AssociatesClinical Research SocietyAmerican Association of Pharmaceutical ScientistsAssociation of British Pharmaceutical Industry ,  Indian Society for Clinical Organization Research (ISCR), Pharmaceutical Information and Pharmacovigilance Association ( PIPA),International Society of Pharmacovigilance (ISOP),  Drug Information AssociationThe Australian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT), European Association for Clinical Pharmacology and Therapeutics (EACPT), European Drug Utilization Research Group (EURODURG

Track 2: Adverse Drug Reactions

These reactions are an open challenge for Healthcare professionals -to understand the problem and be conscious of how these reactions can be prevented and managed. However, adverse drug reactions can be minimized including the patient as one pillar of the therapeutic plan and providing more patient counseling, which will improve drug safety. Assessing and reporting adverse drug reactions are very important to maintain drug safety systems. PK-PD studies are the two principal focus areas of pharmacology. Pharmacodynamics is the study of the molecular, biochemical, and physiological effects of drugs on cellular systems and site of action. Pharmacokinetics focuses on how the body affects the drug, in ADME terms. Today, Clinical Pharmacology techniques and pharmacologists use different techniques to explain and manipulate the pharmacological action for safer use health concerns.

This track provides sound knowledge for drug product manufacturers, professionals, and consumers to report Post marketing reports on adverse effects and informative B2B meetings can be planned.

Related Societies and Associations:

Drug Information AssociationInternational Pharmaceutical FederationEuropean Drug Utilization Research Group(EURODURG), International Society of Pharmacovigilance , Society for Clinical TrialsAssociation of Clinical ResearchThe Society of Clinical Research AssociatesClinical Research SocietyAmerican Association of Pharmaceutical ScientistsAssociation of British Pharmaceutical Industry,  Pharmaceutical Information and Pharmacovigilance Association ( PIPA), International Society of Pharmacovigilance (ISOP),  The Australian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT), European Association for Clinical Pharmacology and Therapeutics (EACPT), International Epidemiology AssociationEuropean Association of Employed Community Pharmacists in Europe (EPhEU), Association of Pharmacy Professionals (APP)

 

Track 3: Clinical Research and Statistics

Pharmacovigilance is an important and integral part of clinical research and these days it is growing in many countries. Bioavailability and bioequivalence studies also plays major role in clinical research. Clinical trials are nothing but experiments done in clinical research. Clinical research system involves a complex network of pharmaceutical companies, sites and educational research institutions/ laboratories. Each clinical trial has a plan of action or a protocol for conducting trial. Clinical trials generate data on safety and efficacy.

Related Societies and Associations:

International Society of Pharmacovigilance , Society for Clinical TrialsAssociation of Clinical ResearchThe Society of Clinical Research AssociatesClinical Research SocietyAmerican Association of Pharmaceutical ScientistsAssociation of British Pharmaceutical Industry ,  Indian Society for Clinical Organization Research(ISCR), Pharmaceutical Information and Pharmacovigilance Association ( PIPA), International Society of Pharmacovigilance (ISOP),  Drug Information AssociationThe Australian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT), European Association for Clinical Pharmacology and Therapeutics(EACPT), European Drug Utilization Research Group (EURODURGInternational Epidemiology AssociationEuropean Association of Employed Community Pharmacists in Europe (EPhEU)

Track 4: Pre-Clinical and Clinical Trials

The main goals of Pre-Clinical and Clinical Trials are to determine the safe dose and start to assess product's safety profile. Concentrating on dosages forms in random clinical trials is very important. Although preclinical studies have revealed many possible mechanisms for these Adverse Events, the causes of some adverse events remain unknown.

Discussions are encouraged on Preclinical and clinical trial mechanisms and their significance, improvements, adversity.

Related Societies and Associations:

Society for Clinical TrialsAssociation of Clinical ResearchThe Society of Clinical Research AssociatesClinical Research SocietyAmerican Association of Pharmaceutical ScientistsAssociation of British Pharmaceutical Industry ,  Indian Society for Clinical Organization Research (ISCR), Pharmaceutical Information and Pharmacovigilance Association ( PIPA), Pharmaceutical Society Of New Zealand (PSNZ), Pharmaceutical Association of Mauritius(PAM),  International Society of Pharmacovigilance (ISOP),  Drug Information AssociationThe Australian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT), European Association for Clinical Pharmacology and Therapeutics (EACPT)

Track 5: Clinical Trials on Various Disorders

Clinical trials are nothing but experiments done in clinical research. Clinical research system involves a complex network of pharmaceutical companies, sites and educational research institutions/ laboratories. Each clinical trial has a plan of action or a protocol for conducting trial. Clinical trials generate data on safety and efficacy.

Here in this track discussions are involved in types of diseases and theirs clinical trial output.

Related Societies and Associations:

The Australian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT), European Association for Clinical Pharmacology and Therapeutics (EACPT), International Pharmaceutical FederationInternational Society of Pharmacovigilance , Society for Clinical TrialsAssociation of Clinical ResearchThe Society of Clinical Research AssociatesClinical Research SocietyAmerican Association of Pharmaceutical ScientistsAssociation of British Pharmaceutical Industry ,  Indian Society for Clinical Organization Research(ISCR), Pharmaceutical Information and Pharmacovigilance Association ( PIPA), International Society of Pharmacovigilance (ISOP)

Track 6: Case Reports in Clinical Trials

In Clinical Research, Case Report plays a prominent role. If an unexpected event in the course of observing, treating a patient, possibilities of pathogenesis of a disease or an adverse effect can drive into action as a Case report.

This track focus on several case reports of clinical trials involving Cancer, Cardiovascular, sexually transmitted diseases, Type 1 and type 2 diabetes, Case reports on drugs used in pregnancy and lactation,  Applications of biomarkers in clinical trials.

Related Societies and Associations:

International Society for PharmacoepidemiologyCenter for Drug Safety and Effectiveness,  Center for Public Health and Human RightsCenter  for Health Services  and Outcomes ResearchInternational Pharmaceutical FederationInternational Society of Pharmacovigilance , Society for Clinical TrialsAssociation of Clinical ResearchThe Society of Clinical Research AssociatesClinical Research SocietyAmerican Association of Pharmaceutical ScientistsAssociation of British Pharmaceutical Industry ,  Indian Society for Clinical Organization Research (ISCR), Pharmaceutical Information and Pharmacovigilance Association ( PIPA)

Track 7: Good Pharmacovigilance Practice

GVP is abbreviated as Good pharmacovigilance practices which is to facilitate the measure and performance of Pharmacovigilance. The role of GVP and Pharmacoepidemiology in Risk Management is to increase the beneficial effects of a drug than its adverse effects.  The clinical trials and pharmacovigilance services providing companies must be Certification. It is of high importance to focus on Signal investigation via observational studies to Interpret safety signals.

This track focuses on role of pharmacovigilance in risk MangementPharmacoepidemiology, Good reporting practices, safety signals Interpretation and many more.

Related Societies and Associations:

International Society of Pharmacovigilance (ISOP),  Drug Information AssociationThe Australian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT), European Association for Clinical Pharmacology and Therapeutics (EACPT), European Drug Utilization Research Group (EURODURGInternational Epidemiology AssociationEuropean Association of Employed Community Pharmacists in Europe(EPhEU), Association of Pharmacy Professionals (APP), Pharmaceutical Society Of New Zealand (PSNZ), Pharmaceutical Association of Mauritius(PAM)

Track 8: Pharmacovigilance Significance & Scope

Medical device Pharmacovigilance is monitoring of safety profile of medical devices, from the processing to reporting of single adverse incidents including the removal of products from the market as fragment of a Field Safety Corrective Action. This to ensure that patient’s and healthcare professional’s safety is monitored and action taken as soon as a safety concern with a medical device arises.

Related Societies and Associations:

International Society for PharmacoepidemiologyCenter for Drug Safety and Effectiveness,  Center for Public Health and Human RightsCenter  for Health Services  and Outcomes ResearchInternational Pharmaceutical FederationInternational Society of Pharmacovigilance , Society for Clinical TrialsAssociation of Clinical ResearchThe Society of Clinical Research AssociatesClinical Research SocietyAmerican Association of Pharmaceutical ScientistsAssociation of British Pharmaceutical Industry ,  Indian Society for Clinical Organization Research (ISCR), Pharmaceutical Information and Pharmacovigilance Association ( PIPA)

Track 9: Pharmacovigilance and Risk Management

Drug safety and pharmacovigilance remains a dynamic clinical and scientific discipline. The regulatory framework for pharmacovigilance in the context of risk management planning, practical aspects of managing biopharmaceutical product risks and benefits in health care delivery system. Pharma Drug industry needs to stimulate companies in pharmacovigilance Practice and Softwares used in Pharmacovigilance and Clinical Trials.

Experts from different CRO’s, Pharmacovigilance Service Providers and Industrial delegates can share knowledge and discuss new updates under this track.

Related Societies and Associations:

International Society of Pharmacovigilance , Society for Clinical TrialsAssociation of Clinical ResearchThe Society of Clinical Research AssociatesClinical Research SocietyAmerican Association of Pharmaceutical ScientistsAssociation of British Pharmaceutical Industry ,  Indian Society for Clinical Organization Research(ISCR), Pharmaceutical Information and Pharmacovigilance Association ( PIPA), International Society of Pharmacovigilance (ISOP),  Drug Information AssociationThe Australian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT), European Association for Clinical Pharmacology and Therapeutics(EACPT), European Drug Utilization Research Group (EURODURGInternational Epidemiology AssociationEuropean Association of Employed Community Pharmacists in Europe (EPhEU)

Track 10: Clinical Data Base Management

Clinical data management is a support for drug development and a perquisite needs to get drugs to market the earlier so that the patients can access to drugs. The team of global clinical data management experts is committed to upholding a standardized, process-driven approach from Phase I through to post-marketing trials.

Related Societies and Associations:

Society for Clinical Data Management, International Pharmaceutical FederationInternational Society of Pharmacovigilance , Society for Clinical TrialsAssociation of Clinical ResearchThe Society of Clinical Research AssociatesClinical Research SocietyAmerican Association of Pharmaceutical ScientistsAssociation of British Pharmaceutical Industry ,  Indian Society for Clinical Organization Research (ISCR), Pharmaceutical Information and Pharmacovigilance Association ( PIPA), International Society of Pharmacovigilance (ISOP),  Drug Information AssociationThe Australian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT), European Association for Clinical Pharmacology and Therapeutics (EACPT), International Epidemiology AssociationEuropean Association of Employed Community Pharmacists in Europe (EPhEU)

Track 11: Analysis of Data quality and Management

Centralizing all safety data, clinical data, analysis and reporting with one provider is advantageous. Pharmacovigilance Software tool provides broad analysis of adverse events arising from the use of Pharmaceutical products (Medical Device, Medicinal Product, Veterinary Medicinal Product, Vaccines, Non-Drug Therapy. The drug safety database permits the risk- benefit analysis of medicinal and medical products taking into account, new and emerging information. Pharmacovigilance is a compliance driven activity, whereas regulatory compliance determines company’s risk assessment scores. A drug safety database provides follow-up cases, scheduling of alerts for expedited cases and PADER /PSUR reports submission to meet regulatory timeline compliance.

Related Societies and Associations:

International Society for PharmacoepidemiologyCenter for Drug Safety and Effectiveness,  Center for Public Health and Human RightsCenter  for Health Services  and Outcomes ResearchInternational Pharmaceutical FederationInternational Society of Pharmacovigilance , Society for Clinical TrialsAssociation of Clinical ResearchThe Society of Clinical Research AssociatesClinical Research SocietyAmerican Association of Pharmaceutical ScientistsAssociation of British Pharmaceutical Industry ,  Indian Society for Clinical Organization Research (ISCR), Pharmaceutical Information and Pharmacovigilance Association ( PIPA)

Track 12: PV Consultings And Business opportunity

Owing to the changing resources which are necessary to fulfil the regulatory requirements, few companies choose to outsource or out task regulatory affairs to service providers externally. Regulatory Affairs department is constantly evolving and growing and hence it is one which is least impacted during the Acquisition and Merger, and also during recession. The stringent regulations on safety monitoring and their periodical revision have led to increased safety in data collection, analysis, regulatory surveillance including costs. Thus, Pharmacovigilance has become a critical phase in clinical development programs.

Related Societies and Associations:

International Society for PharmacoepidemiologyCenter for Drug Safety and Effectiveness,  Center for Public Health and Human RightsCenter  for Health Services  and Outcomes ResearchInternational Pharmaceutical FederationInternational Society of Pharmacovigilance , Society for Clinical TrialsAssociation of Clinical ResearchThe Society of Clinical Research AssociatesClinical Research SocietyAmerican Association of Pharmaceutical ScientistsAssociation of British Pharmaceutical Industry ,  Indian Society for Clinical Organization Research (ISCR), Pharmaceutical Information and Pharmacovigilance Association ( PIPA)

Track 13: Biopharmaceutics

This is a main branch in Pharmaceutical Sciences which relates the physicochemical properties of the drugs - dosage form, pharmacology, toxicology / clinical response observed after its administration. Biopharmaceuticsuses the exact formulation to obtain the drug with new dosage form as related to the onset, duration, and intensity of drug action, including constituents and mode of manufacture.

Discussions under this track include rational drug management of cancer, diabetes and cardiovascular disorders, Management of psychiatric disorders and autoimmune disorders, Bioavailability and bioequivalence, drug disposition, Invivo-invitro correlation, Pharmacodynamics, Drug Interaction, Bio analytical method, Clinical Pharmacology, Clinical toxicology, Biomarkers, Recent Biomedical Innovation

Related Societies and Associations:

International Society of Pharmacovigilance (ISOP),  Drug Information AssociationThe Australian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT), European Association for Clinical Pharmacology and Therapeutics (EACPT), European Drug Utilization Research Group (EURODURGInternational Epidemiology AssociationEuropean Association of Employed Community Pharmacists in Europe(EPhEU), Association of Pharmacy Professionals (APP), Pharmaceutical Society Of New Zealand (PSNZ), Pharmaceutical Association of Mauritius(PAM)

Track 14: Regulatory Affairs

Regulatory Affairs is involved in all the stages of development of a new medicine and its post-marketing activities with medicinal products authorities. This department heart of pharmaceutical industry. Internally it is a cluster of drug development, drug manufacturing, drug marketing and clinical research. Outward it is an interface between the company and regulatory authorities. In the Clinical trial approaches, major role is played by regulatory affairs for clinical trials. According to regulatory affairs guidelines clinical trials are to be conducted. Regulatory affairs are independent for specific country and their guidelines. International harmonization in principles has led to consistent approach in regulatory submissions and hence its review.

Related Societies and Associations:

International Society for PharmacoepidemiologyCenter for Drug Safety and Effectiveness,  Center for Public Health and Human RightsCenter  for Health Services  and Outcomes ResearchInternational Pharmaceutical FederationInternational Society of Pharmacovigilance , Society for Clinical TrialsAssociation of Clinical ResearchThe Society of Clinical Research AssociatesClinical Research SocietyAmerican Association of Pharmaceutical ScientistsAssociation of British Pharmaceutical Industry ,  Indian Society for Clinical Organization Research (ISCR), Pharmaceutical Information and Pharmacovigilance Association ( PIPA),

 International Society of Pharmacovigilance (ISOP),  Drug Information AssociationThe Australian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT), European Association for Clinical Pharmacology and Therapeutics (EACPT), European Drug Utilization Research Group (EURODURGInternational Epidemiology AssociationEuropean Association of Employed Community Pharmacists in Europe(EPhEU), Association of Pharmacy Professionals (APP), Pharmaceutical Society Of New Zealand (PSNZ), Pharmaceutical Association of Mauritius(PAM)

Track 15: Pharmacy Practices and its Challenges

In Pharmacy Practices and its Challenges track principally targeted on Pharmacy observe and its pointers and Challenges in change of integrity and dispensing observe. Indefinite quantity program, drug toxicity and drug safety measures place vital position in clinical analysis. Strategies for Growth in pharmaceutical company atmosphere are targeted in Strategic development towards bureau approval and Post market product Surveillances.

Related Societies and Associations:

European Association of Employed Community Pharmacists in Europe (EPhEU), Association of Pharmacy Professionals (APP), Pharmaceutical Society Of New Zealand (PSNZ), Pharmaceutical Association of Mauritius(PAM), Pharmaceutical Information and Pharmacovigilance Association ( PIPA), Drug Information AssociationThe Australian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT), European Association for Clinical Pharmacology and Therapeutics (EACPT), European Drug Utilization Research Group (EURODURGInternational Epidemiology Association

Track 16: Entrepreneurs Investment Meet

A platform aimed to connect Entrepreneurs, Investors, and Proposers globally. It's intended to create and facilitate industrial delegates, research scientists, business delegate a viable meeting place for engaging people and it would be a good opportunity for Startup Company representatives in global business discussions, evaluation and execution of promising business ideas. For entrepreneurs, it would be an ideal place to find out suitable investors and partners to start and/or expand their business. 

 

Market Analysis

Global Pharmacovigilance Market is expected to reach USD 5.51 billion by 2020, according to a new study by Grand View Research, Inc. Increasing incidence rates of adverse drug reaction and the introduction of stringent drug safety regulations are some key drivers of this market. ADR is responsible for approximately 5% of the hospitalization in developed countries annually, and this is expected to boost usage rates over the next six years. Pharmacovigilance has witnessed a significant rise in usage rates in the recent times owing to growing global geriatric population triggering a growth in demand for new drug development. Additionally, health regulatory authorities such as the U.S. FDA and EMEA (European Medicines Agency) are now emphasizing on electronic submission of data which is also expected to drive the pharmacovigilance market.

Contract outsourcing pharmacovigilance market is expected to grow at a lucrative rate of over 13.1% during the forecast period. Service flexibility and cost effectiveness associated with outsourcing are some key factors accounting for the segment’s lucrative growth.

Further key findings from the study suggest: Global Pharmacovigilance Market is expected to reach USD 5.51 billion by 2020, according to a new study by Grand View Research, Inc. Increasing incidence rates of adverse drug reaction and the introduction of stringent drug safety regulations are some key drivers of this market. ADR is responsible for approximately 5% of the hospitalization in developed countries annually, and this is expected to boost usage rates over the next six years. Pharmacovigilance has witnessed a significant rise in usage rates in the recent times owing to growing global geriatric population triggering a growth in demand for new drug development. Additionally, health regulatory authorities such as the U.S. FDA and EMEA (European Medicines Agency) are now emphasizing on electronic submission of data which is also expected to drive the pharmacovigilance market.

Contract outsourcing pharmacovigilance market is expected to grow at a lucrative rate of over 13.1% during the forecast period. Service flexibility and cost effectiveness associated with outsourcing are some key factors accounting for the segment’s lucrative growth.

  • Pharmacovigilance services found the largest application in phase 4/IV clinical trial studies in 2013. Greater applicability and relevance are some factors accounting for the segment’s market position.
  • Contract outsourcing was the most revenue generating service provider segment in 2013. Minimization of upfront investments and reduction in fixed overhead costs are some factors expected to drive segment growth.
  • North America was the largest regional market, accounting for over 40.0% of the revenue in 2013. Presence of stringent healthcare regulations implemented by the U.S. FDA and high market penetration rates of electronic medical records are some factors responsible for its large share.  
  • Asia Pacific is identified as the most lucrative market. Presence of a large pool of skilled labor and favorable business environments are some factors expected to drive regional market growth. Rapidly improving healthcare infrastructure in the emerging economies of India and China is also expected to provide new growth opportunities to the market participants.
  • Key players of this market include Quintiles Transnational Corporation, PAREXEL International, Clinquest Group BV, Pharmaceutical Product Development, Accenture Plc., Boehringer Ingelheim GmbH and Cognizant Technology Solutions
  • Providing customized end to end PV solutions & services and entering into strategic agreements are some key strategies adopted by these market players.

 

Global pharmacovigilance market, by clinical trials, 2012 – 2020 (USD Million)

 

Past Conference Report

Global Pharmacovigilance 2017

Our Cordial thanks to all of our wondrous and famed speakers, conference attendees, students, doctors and guests for shaping Global Pharmacovigilance 2017 an ineradicable event and a mile stone.

Conference Series LLC hosted the 8th Global Pharmacovigilance & Drug Safety Summit during July 06-07, 2017 at Kuala Lumpur, Malaysia. The conference was designed around the theme of “Innovations in Pharmacovigilance for Systematic Safety and Management” and was a great success where eminent keynote speakers from various reputed companies made their resplendent presence and addressed the gathering. Moreover, the networking sessions laid the foundation for some time worthy collaborations between many start-up and big industries. The post conference networking lunch session witnessed a number of B2B meetings that are turning up to be mutually beneficial to both the organizations who had gone in for the business meetings.

Global Pharmacovigilance 2017 witnessed an amalgamation of peerless speakers who enlightened the crowd with their knowledge and confabulated on various new-fangled topics related to the field of Pharmacovigilance and Drug Safety. This congress not only brought forward the latest developments in the field but also provided solutions to the numerous challenges encountered in drug development and pharmacovigilance.

Conference Series LLC would like to convey a warm gratitude to all the Honourable guests, Keynote Speakers, Delegates and Media Partners for their participation in Global Pharmacovigilance 2017. The conference was initiated with a series of lectures delivered by both Honorable Guests and members of the Keynote forum.

 
We on behalf of the conference specially thank Abhay for his support as a moderator for the conference. Conference Series LLC also took the privilege of felicitating Global Pharmacovigilance 2017 Organizing Committee, Keynote Speakers, and Chair whose support made conference a great success with various sessions and multiple presentations.

With the enormous feedback from the participants and supporters of Global Pharmacovigilance 2017, we are glad to announce 11th Global Pharmacovigilance & Clinical Trials Summit during July 09-10, 2018 at Sydney, Australia.

For More details visit: Global Pharmacovigilance 2018


Past Reports  Proceedings  Gallery  

Supported By

Journal of Clinical Trials Journal of Pharmacovigilance Journal of Clinical & Experimental Pharmacology

All accepted abstracts will be published in respective Conferenceseries International Journals.

Abstracts will be provided with Digital Object Identifier by